Amicus Therapeutics
$9.809876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$9.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (0.10%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell FOLD and other stocks, options, ETFs, and crypto commission-free!
About FOLD
Amicus Therapeutics, Inc. engages in the discovery, development, and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. Read More The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.
Employees
508
Headquarters
Cranbury, New Jersey
Founded
2002
Market Cap
2.50B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
3.92M
High Today
$9.91
Low Today
$9.59
Open Price
$9.75
Volume
1.85M
52 Week High
$14.62
52 Week Low
$8.27
Collections
Price Paid on Robinhood
19% Lower
Right Now
52 Week Low
$8.27
Average Price Paid
$12.08
52 Week High
$17.62
Analyst Ratings
83%
of 12 ratings
Buy
83%
Hold
17%
Sell
0%
FOLD Earnings
-$0.41
-$0.37
-$0.32
-$0.28
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, Pre-Market